Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
History of Hepatitis C in Volunteer Blood Donors Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on History of Hepatitis C in Volunteer Blood Donors conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. History of Hepatitis C in Volunteer Blood Donors Clinical research trials and History of Hepatitis C in Volunteer Blood Donors health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like History of Hepatitis C in Volunteer Blood Donors. History of Hepatitis C in Volunteer Blood Donors Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a History of Hepatitis C in Volunteer Blood Donors clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their History of Hepatitis C in Volunteer Blood Donors condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "H" Clinical Trials Conditions > History of Hepatitis C in Volunteer Blood Donors

History of Hepatitis C in Volunteer Blood Donors



History of Hepatitis C in Volunteer Blood Donors

For Condition: Hepatitis C
Status: Completed
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: Hepatitis C is a disease of the liver caused by the Hepatitis C Virus (HCV). Patients with hepatitis C may feel well and show no signs or symptoms of being ill. However, researchers would like to study the long-term effects of this disease. Volunteer blood donors diagnosed with chronic hepatitis C viral (HCV) and various levels of liver enzyme activity will be offered a complete medical evaluation and liver biopsy. The tests will enable researchers to provide the patients with an idea of how severe their liver disease is. The virus and patient will be studied in order to understand why patients with hepatitis C develop different levels of liver damage.
Details: A selected sample of volunteer blood donors with chronic hepatitis C viral (HCV) infection and various levels of serum aminotransferase activity will be offered a complete medical evaluation and liver biopsy to determine the severity of their liver disease. Various virological and host factors will be studied in an attempt to determine why patients with HCV infection develop differing degrees of liver disease.
Eligibility:
Study Type:
  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients with chronic hepatitis C. Age 18 to 70 years, male or female. HCV infection indicated by the presence of anti-HCV (by ELISA and recombinant immunoblot assay [RIBA]). Written informed consent. Women must not be pregnant. Patients must not have significant systemic illnesses other than liver disease, including congestive heart failure, renal failure, uncontrolled diabetes mellitus. Patients must not have antiviral or immunosuppressive therapy within the last 6 months. Patients must not have HIV infection. Patients must not have contraindications to liver biopsy (mainly clotting abnormality (coumadin therapy, platelet count less than 50,000/cubic millimeter, prothrombin time more than 4 seconds beyond control)).
Total Enrollment: 60

Location and Contact Information:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Bethesda,  Maryland,  20892
United States
 


Additional Information:
Study ID Numbers:
  930159;  93-DK-0159
Study Start Date: June 11, 1993
Record last reviewed: May 6, 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001982

Other Hepatitis C Studies:
1. Immune Response to Hepatitis C Virus

2. Herbal Treatment of Hepatitis C in Methadone Maintained Patients

3. Genetics of Hepatitis C Virus Infection

4. Racial Differences in Hepatitis C Virus (HCV)/Host Interactions

5. Hepatitis C Antiviral Resistance in African-Americans

Related Studies:

Other Hepatitis C Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

History of Hepatitis C in Volunteer Blood Donors

Modify your Search

  Other Hepatitis C Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103